LP
Schedule 13D filing
Legion Partners Asset Management, LLC disclosed a 17.3% stake in Lifecore Biomedical, Inc. \De\ (LFCR)
Legion Partners Asset Management, LLC reported owning 17.3% of Lifecore Biomedical, Inc. \De\ (LFCR) (6,991,919 shares) in a Schedule 13D filed Sep 28, 2026.
A 13D means the holder may push for changes at the company.
- Disclosed
- Sep 28, 2026
- Source
- Schedule 13D
From a public Schedule 13D, linked above. Not investment advice, and not a recommendation to buy or sell.